Skip to main content
FMC logo

FMC · Fmc Corp

Track FMC — free
$4.64 -0.36 (-7.11%)
Market Cap
$776.24M
Shares
155.56M
Volume · Nov 18 1.16M Avg daily vol (3M) 5.91M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.99 Open$5.25 Day$4.91–5.28 52W close$4.47–18.07 Avg vol 30d8.3M Short int38.4M · 24.7% of shares · 3.8d Short vol56% Last earningsOct 30, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 30

Up next

Feb 4, 2027 Est · unconfirmed · in 11 wks

Latest documents

2026
Oct 30
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Three-month revenue falls 80% on $672 million commercial action charges

FMC Corporation reported revenue of $105.9 million for the three months ended September 30, 2026, down about 80 percent, after commercial actions led to charges of approximately $672 million. Net loss attributable to FMC stockholders reached $2,066.9 million.

Revenue $105.9M ▼ 80.5% Net loss $2.07B Diluted EPS -$15.54
Read from the MD&A section
3 source passages
Revenue of $105.9 million for the three months ended September 30, 2026 decreased $436.3 million, or approximately 80 percent, versus the prior year period As a result, we recorded charges of approximately $672 million during the three months ended September 30, 2026, which includes approximately $639 million recorded to Revenue Net loss attributable to FMC stockholders for the three months ended September 30, 2026 of $2,066.9 million increased $1,497.6 million Open the document at this passage
Oct 30
Earnings call
Third-Quarter EBITDA Negative $559 Million After $672 Million Commercial Charges

FMC reported third-quarter adjusted EBITDA of negative $559 million, including $672 million from commercial actions that reduce channel inventory value. It guides fourth-quarter EBITDA to $210 million to $230 million.

3 source passages
Third quarter adjusted EBITDA was negative $559 million, including approximately $672 million associated with the commercial action. To address this issue, we are taking two actions to reduce the value of their FMC channel inventory. I just said EBITDA is expected to be between $210 million and $230 million, a decline of 22% versus the prior. Open the document at this passage
Oct 29
Current report 8-K
Financial results

FMC Corporation reported third-quarter 2026 revenue of $106 million, GAAP net loss of $2.07 billion and Adjusted EBITDA of negative $559 million. Full-year free cash flow is expected to be negative $350 million to negative $150 million.

Oct 21
Current report 8-K
Director or officer change, or executive pay

FMC Corporation increased its Board from 9 to 10 directors and appointed Luc Tack effective October 21, 2026, also assigning him to the Sustainability & Innovation Committee.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.81B
Trailing 12 months
Net income (TTM)
−$4.26B
Trailing 12 months
Revenue growth YoY
-80.5%
Year over year
Operating margin
-97.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
47.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$3.44B
Latest balance sheet
Dividend yield
6.4%
Trailing 12 months
Shares change YoY
+6.3%
Year over year · more shares
Price change (1Y)
-61.5%
Trailing year
Short interest
24.7%
Latest settlement · 3.8 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 30, 2026
Q3 FY26

TL;DR. FMC reported third-quarter revenue of $106 million, adjusted EBITDA of negative $559 million and adjusted EPS of negative $4.41 after approximately $672 million of commercial-action charges, and guided fourth-quarter revenue to $1.04 billion–$1.14 billion, adjusted EBITDA to $210 million–$230 million and adjusted EPS to $0.56–$0.70. It reduced 2026 free-cash-flow guidance to negative $350 million–negative $150 million, while commercial actions, preliminary 2027–2028 adjusted EBITDA growth, pending transaction proceeds and expected year-end deleveraging offer potential future improvement.

Bullish
  • + Commercial actions are expected to accelerate product movement through the channel and support future replenishment demand.
  • + Preliminary planning indicates 2027 adjusted EBITDA of at least $650 million and as much as $730 million.
  • + Preliminary planning indicates 2028 adjusted EBITDA of approximately $760 million to $840 million and much stronger cash generation.
  • + Management believes break-even 2027 free cash flow before restructuring is possible.
  • + Third-quarter free cash flow improved $214 million year over year despite the commercial-action charges.
Bearish
  • − Third-quarter results fell below initial guidance, with revenue of $106 million, adjusted EBITDA of negative $559 million and adjusted EPS of negative $4.41 after approximately $672 million of commercial-action charges.
  • − The approximately $175 million channel-inventory adjustment is the only component of the commercial charges expected to reduce future cash collection.
  • − FMC recorded approximately $809 million of deferred-tax-asset adjustments and a $288 million non-cash intangible-asset impairment charge.
  • − Full-year 2026 interest expense is expected to be $270 million–$280 million, up approximately $35 million versus the prior year at the midpoint.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 25.5 · fear Equity put/call 0.71
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −58%
below
Price vs 50-day avg −35%
below
RSI (14) 36
neutral
MACD trend Positive
52-week position 4%
near low
Momentum
relative strength
Very Weak
1-month return −6%
trailing
6-month return −63%
trailing
YTD return −64%
this year
Relative strength −60%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $8 › 200d $12 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +60 funds added
Insider flow Distributing
Net -$1.9K over 90 days · 50% sells
Short interest Rising
24.69% of shares out · ▲ +26.0% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
388 holders — near 3-yr low, contrarian setup
Squeeze score 72
high risk · 0–100
Fundamentals
Fair
Revenue growth +69%
Y/Y
Gross margin 30%
contracting
EPS growth −757%
Y/Y
Buyback $825.0M
remaining
Balance sheet $3.5B
net debt
Quant / Vol
risk profile
Very High
Volatility 76%
annualized · 1-yr
Max drawdown −75%
past year
ATR 11.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 8
Latest guidance · from the 8-K filed Oct 29, 2026
Fourth quarter
Fourth-quarter revenue, excluding India Non-GAAP Initiated $1.04B – $1.14B
Adjusted EBITDA Non-GAAP Lowered $210M – $230M
Jul 29, 2026 $275M – $315M changed to Oct 29, 2026 $210M – $230M
Adjusted earnings per diluted share Non-GAAP Lowered $0.56 – $0.70
Jul 30, 2026 $1.09 – $1.33 changed to Oct 29, 2026 $0.56 – $0.70
Full-year 2026
Full-year revenue, excluding India Non-GAAP Initiated $2.75B – $2.85B
Restructuring spend Initiated $180M
Previous outlook earlier release · from the 8-K filed Apr 29, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EBITDA · Full-Year 2026 $670M – $730M
Sales of new active ingredients · Full-Year 2026 $300M – $400M
Prior guidance period ended · from the 8-K filed Oct 15, 2026
Third-quarter revenue · third quarter 2026 $65M – $125M
Guided vs delivered · last 8 settled
Revenue full year
guided $3.92B – $4.02B
$3.47B Miss −12.7%
Revenue Third Quarter 2024
guided $1B – $1.09B
$1.07B In line
Revenue Fourth Quarter 2024
guided $1.34B – $1.45B
$1.22B Miss −12.2%
Revenue Full Year 2024
guided $4.5B – $4.7B
$4.25B Miss −7.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−58% Bearish
Price vs 50-day avg
−35% Bearish
RSI (14)
36 Neutral
MACD trend
Positive Bullish
52-week position
4% Bearish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $8 › 200d $12 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +60 funds added
Insider flow Distributing
Net -$1.9K over 90 days · 50% sells
Short interest Rising
24.69% of shares out · ▲ +26.0% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
388 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $4 Now $5 · 4% Range high $18
vs 200-day avg -58% vs 50-day avg -35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted loss per diluted share non-GAAP $4.41 Third Quarter 2026 —
Diluted adjusted after-tax earnings (loss) from continuing operations per share, attributable to non-GAAP -$4.54 Nine Months Ended September 30, 2026 —
Organic revenue (non-GAAP) change non-GAAP -42% Nine Months Ended September 30, 2026 vs. 2025 —
restructuring spend $23M Third Quarter 2026 —
ROIC numerator (non-GAAP) non-GAAP -199.3M Twelve Months Ended September 30, 2026 —
underlying Adjusted EBITDA non-GAAP $113M Third Quarter 2026 —
Adjusted EBITDA (non-GAAP) non-GAAP $152.6M Three Months Ended June 30, 2026 filing —
Organic Revenue Change (non-GAAP) non-GAAP -22% Three Months Ended June 30, 2026 vs. 2025 filing —
Adjusted earnings per diluted share non-GAAP $0.26 second quarter 2026 —
Adjusted ROIC (using non-GAAP numerator) (1) non-GAAP 6.8% Twelve Months Ended June 30, 2026 —
Free cash flow (non-GAAP) (3) non-GAAP -$270.7M Six Months Ended June 30, 2026 —
Organic revenue non-GAAP -22% second quarter 2026 —
Organic revenue (non-GAAP) change (2) non-GAAP -16% Six Months Ended June 30, 2026 vs. 2025 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Agricultural Inputs — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FMC
Fmc Corp
this stock
$776.24M -64.0% +69.3% — 24.7%
NTR
Nutrien Ltd.
$32.82B +12.2% — — 1.8%
CF
CF Industries Holdings, Inc.
$17.46B +54.3% +19.3% 8.4 6.1%
YARIY
Yara International ASA
$10.46B +0.6% — — 0.0%
MOS
Mosaic Co
$6.59B -13.9% +8.4% — 11.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
388
% held
81.2%
Net QoQ
-1.9M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
318
View
Short & Settlement
Short Interest Rising
Shares short
38.4M
Days to cover
3.8d
Change
+7.9M sh
View
Short Volume
Short vol %
56%
As of
Nov 17, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$7.4K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
48.9%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.9K
Buyers / Sellers
1 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Dan Newhouse
Amount
$1.0K–$15.0K
Traded
Jul 10, 2026
View
Financials
Financials
Revenue (FY)
$3.5B
Net income (FY)
$-2.2B
EPS diluted
$-17.88
View
Buybacks
Authorized
$1.0B
Remaining
$825.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 30, 2026
This year
29

FMC Corporation reported revenue of $105.9 million for the three months ended September 30, 2026, down about 80 percent, after commercial actions led to charges of approximately $672 million. Net loss attributable to FMC stockholders reached $2,066.9 million.

View
Proposed Sales
Value
$32.3K
Shares
4.9K
Filed
Nov 3, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 30, 2026
View
Investor Relations
Latest news
FMC Corporation Reports Third-Qua…
Published
Oct 29, 2026
View

Performance

5D 20D 120D MTD YTD
FMC -11.5% -6.0% -63.2% -19.5% -64.0%
SPY -2.3% -4.8% -2.9% -3.1% +7.4%
vs SPY -9.2% -1.3% -60.3% -16.4% -71.4%

Capital returns

Latest dividend
$0.08 / share · ex Sep 30, 2026
Cut 86.2%
Paid (TTM)
$0.32 / share · 4 payouts
Dividend yield (TTM, derived)
6.41%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$1.00B
Spent (derived)
$175.00M
Remaining
$825.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 37785 CUSIP 302491303 13F (30d) 421 filings 359 filers Visit website Investor relations